Rocket Lab (NASDAQ:RKLB) Shares Up 2.8% - Time to Buy?

Key Points

• Rocket Lab shares rose 2.8% to $75.06 on higher-than-average trading volume, while analysts maintained a generally bullish outlook with a “Moderate Buy” consensus and an average price target of $107.20.
• Growth prospects are supported by a 20-launch Electron contract with Synspective, potential NASA lunar-base launch demand and an opportunity created by SpaceX’s planned reduction in Falcon 9 rideshare sales after 2028.
• Despite strong revenue growth and diversification into spacecraft and components, Rocket Lab remains unprofitable and richly valued; its outlook depends heavily on successful Neutron development, timely launches and continued contract wins.

Rocket Lab Corporation (NASDAQ:RKLB - Get Free Report) rose 2.8% during trading on Tuesday. The stock traded as high as $78.28 and last traded at $75.06. 26,821,828 shares were traded during trading, an increase of 16% from the average daily volume of 23,092,809 shares. The stock had previously closed at $73.02.

Rocket Lab News Summary

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: NASA is reportedly preparing a bulk purchase of rocket launches to support its planned permanent moon base, potentially creating a significant new source of orders for Rocket Lab. The report also highlights strong industry demand and limited launch capacity. Rocket Lab Stock Pops Tuesday: What's Going On?
• Positive Sentiment: SpaceX’s planned exit from new Falcon 9 rideshare sales after 2028 could open a sizable market for Rocket Lab’s planned Neutron vehicle. Rocket Lab’s backlog suggests potential demand, while ARK Investment Management called the launch bottleneck an opportunity for Rocket Lab and other emerging providers if their rockets perform as planned. Can Rocket Lab Capitalize on Falcon 9’s Exit Before Neutron Slips Again
• Positive Sentiment: Rocket Lab recently secured a 20-launch Electron contract with Synspective, its largest commercial Electron agreement to date. The deal reinforces customer demand and supports expectations for a higher, more consistent launch cadence. Rocket Lab Could Be 14% Undervalued Following Its 20 Launch Synspective Deal
• Neutral Sentiment: Investors are also highlighting Rocket Lab’s expansion beyond launches, including spacecraft manufacturing, vertical integration, supply-chain investments and its IMM Apex solar-cell product. These initiatives could diversify revenue, but their effect on near-term earnings remains uncertain. Can Rocket Lab’s Supply-Chain Strategy Support Future Growth?
• Negative Sentiment: Despite rapid revenue growth, Rocket Lab remains unprofitable and trades at an aggressive valuation. Analysts caution that the stock’s future upside depends heavily on successful Neutron development, timely launches and continued contract wins; delays or execution problems could pressure the shares. Rocket Lab Is Growing Fast, but Profitability Is Still a Challenge

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on RKLB shares. KeyCorp reissued an "overweight" rating on shares of Rocket Lab in a report on Tuesday, August 11th. Roth Capital set a $110.00 price target on Rocket Lab in a research report on Tuesday, August 11th. Weiss Ratings reissued a "sell (d-)" rating on shares of Rocket Lab in a report on Friday, July 17th. Citigroup began coverage on shares of Rocket Lab in a research report on Thursday, October 1st. They set a "buy" rating and a $105.00 price objective for the company. Finally, Citizens Jmp reiterated a "market outperform" rating and issued a $130.00 target price on shares of Rocket Lab in a research report on Tuesday, August 11th. Four research analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $107.20.

Rocket Lab Price Performance

The business's 50-day moving average price is $69.89 and its 200 day moving average price is $84.39. The company has a market capitalization of $44.91 billion, a P/E ratio of -277.99 and a beta of 2.93. The company has a quick ratio of 4.98, a current ratio of 5.48 and a debt-to-equity ratio of 0.01.

Rocket Lab (NASDAQ:RKLB - Get Free Report) last released its earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The business had revenue of $234.07 million for the quarter, compared to the consensus estimate of $231.62 million. Analysts anticipate that Rocket Lab Corporation will post -0.2 EPS for the current fiscal year.

Insider Activity at Rocket Lab

In related news, CAO Agostino Ricupati sold 669 shares of the firm's stock in a transaction on Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $46,582.47. Following the completion of the transaction, the chief accounting officer owned 26,863 shares in the company, valued at $1,870,470.69. This trade represents a 2.43% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Frank Klein sold 35,558 shares of the business's stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $66.61, for a total transaction of $2,368,518.38. Following the completion of the sale, the insider directly owned 925,737 shares of the company's stock, valued at approximately $61,663,341.57. The trade was a 3.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,391,709 shares of company stock worth $109,075,420 in the last three months. Corporate insiders own 8.40% of the company's stock.

Institutional Trading of Rocket Lab

Hedge funds and other institutional investors have recently bought and sold shares of the company. Byrne Asset Management LLC acquired a new stake in Rocket Lab during the 3rd quarter worth approximately $42,000. Ballew Advisors Inc purchased a new stake in shares of Rocket Lab in the 3rd quarter valued at approximately $278,000. Eastern Bank acquired a new position in Rocket Lab during the third quarter worth $216,000. CX Institutional lifted its position in shares of Rocket Lab by 52,312.8% during the 3rd quarter. CX Institutional now owns 126,839 shares of the rocket manufacturer's stock worth $8,838,000 after purchasing an additional 126,597 shares during the last quarter. Finally, Versant Capital Management Inc raised its stake in shares of Rocket Lab by 366.8% in the third quarter. Versant Capital Management Inc now owns 9,564 shares of the rocket manufacturer's stock valued at $666,000 after purchasing an additional 7,515 shares in the last quarter. 71.78% of the stock is owned by hedge funds and other institutional investors.

Rocket Lab Company Profile

Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.

Rocket Lab's primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.